It seemed like a good idea. Spit into a plastic vial, drop it in the mail and six weeks later get genetic information.
I would know if I'm predisposed to Alzheimer's or Parkinson's disease, breast cancer, diabetes and more -- hundreds of traits and conditions, according to 23andMe, the company supplying the test kit.
Genetic testing, the Holy Grail of medicine, is upon us.
"In five years, every newborn will leave the hospital with his or her complete genetic code," said futurist David Houle of Chicago.
Indeed, the race is on now to get all kinds of genetic information to consumers with at-home testing kits. Several companies have been selling the kits over the Internet, but it soon will be easier and cheaper. On Friday, Pathway Genomics of San Diego plans to start selling its at-home genetic testing kits at Walgreens, and undercutting the price of the competition -- $79 to $449, depending on the lab work, instead of $399 to $2,000.
The race is a testament to the power of the product. Unique to each person, genetic information can deliver targeted, personalized health care and a longer, healthier life if you know your particular genetic strengths and weaknesses.
It's the kind of information long promised to revolutionize medicine.
But there are a few catches.